RxDoctor Payments Data

Caren Mikesh, MD

Procedural Dermatology · Naples, FLNPI 1770518144

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 23.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $143 and has fallen 92.4% since, to $11 in 2025. That places this record below the midpoint for procedural dermatology clinicians in FL, where the typical reported total is $1,299.

$345in general payments, 2019–2025

Across 17 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$81
  • Almirall LLC$71
  • Johnson & Johnson$62
  • Sun Pharmaceutical Industries Inc.$42
  • AbbVie$34
  • Novartis$16
  • plus $39 from 3 others

What the payments were for

  • Food & beverage$345100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$345 in reported general payments places this provider in the 25th percentile of 60 procedural dermatology providers in Florida.

See all procedural dermatology providers in Florida

Medicare billing

Part B allowed, 2024
$405,004
Medicare patients
1,055
Services billed
5,801

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab12$53,004
JubliaEfinaconazole16$14,332
Fluorouracil134$8,585
Clobetasol Propionate76$3,947
Imiquimod73$2,061
Tretinoin27$1,835
Doxycycline Hyclate25$1,136
Desonide32$1,015
Triamcinolone Acetonide50$914
Ketoconazole58$646
Mupirocin43$362
Clindamycin Phosphate11$245
ValacyclovirValacyclovir Hcl25$230

Paid to pharmacies, not to this prescriber.

Other procedural dermatology in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →